https://www.marketscreener.com/quote/stock/LEXICON-PHARMACEUTICALS-I-9868/news/Lexicon-Pharmaceuticals-Completes-Enrollment-In-Pivotal-Phase-3-Clinical-Trial-Of-Telotristat-Etip-19995662/?utm_source=telegram&utm_medium=social&utm_campaign=share